First Page | Document Content | |
---|---|---|
![]() Date: 2014-03-26 10:08:06Rare diseases Fabry disease Enzyme replacement therapy Lysosomal storage disease Stroke Aspirin Fabry Robert J. Desnick Health Medicine Lipid storage disorders | Add to Reading List |
![]() | Migalastat and Enzyme Replacement Therapy Have Comparable Effects on Renal Function in Fabry Disease: Phase 3 Study Results Nicholls, K1*, Bichet, DG2, Giugliani, R3, Hughes, D4, Schiffmann, R5, Wilcox, W6, Skuban, N7, RDocID: 1tiPw - View Document |
![]() | The Journal of Rare Disorders CochraneCornerDocID: 19CDW - View Document |
![]() | 7 November 2014 Dear Committee Re: Life Saving Drugs Programme Review Fabry Support Group of Australia SubmissionDocID: W87d - View Document |
![]() | Minimum Recommended Schedule of Assessments for MPS I Patients Initial Assessments Every 6DocID: VV2Y - View Document |
![]() | Pancreatic enzyme replacement therapyDocID: V3Jk - View Document |